Michele Peake Andrasik1, Christian Chandler, Borris Powell, Damon Humes, Steven Wakefield, Katharine Kripke, Daniel Eckstein. 1. Michele Peake Andrasik and Steven Wakefield are with the HIV Vaccine Trials Network (HVTN), Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA. Christian Chandler is with the University of South Florida, Morsani College of Medicine, Tampa. At the time of writing and data collection, respectively, Borris Powell and Damon Humes were with HVTN Legacy Project, FHCRC, Seattle. Katharine Kripke is with Futures Institute, Washington, DC. Daniel Eckstein is with NOVA Research Company, Bethesda, MD.
Abstract
OBJECTIVES: We obtained contextual information regarding documented barriers to HIV clinical trial participation among Black men who have sex with men (MSM), and explored current preventive HIV clinical trial attitudes, beliefs, and perceptions among Black MSM leaders in the United States. METHODS: We conducted 2 focus groups with Black MSM leaders attending an annual African American MSM Leadership Conference on HIV/AIDS. Focus group questions explored biomedical research perceptions and attitudes, barriers to participation in biomedical prevention research, and steps that need to be taken to address these barriers. A feedback and member checking (participants presented with final themes to provide feedback and guidance) session was also held at the 2012 conference. RESULTS: Three distinct themes emerged regarding Black MSM engagement and participation in HIV vaccine research: (1) community-based organizations as true partners, (2) investment in the Black gay community, and (3) true efforts to inform and educate the community. CONCLUSIONS: A key focus for improving efforts to engage the Black MSM community in preventive HIV clinical trials is building and maintaining equitable and reciprocal partnerships among research institutions, Black-led AIDS service organizations and community-based organizations, and community members.
OBJECTIVES: We obtained contextual information regarding documented barriers to HIV clinical trial participation among Black men who have sex with men (MSM), and explored current preventive HIV clinical trial attitudes, beliefs, and perceptions among Black MSM leaders in the United States. METHODS: We conducted 2 focus groups with Black MSM leaders attending an annual African American MSM Leadership Conference on HIV/AIDS. Focus group questions explored biomedical research perceptions and attitudes, barriers to participation in biomedical prevention research, and steps that need to be taken to address these barriers. A feedback and member checking (participants presented with final themes to provide feedback and guidance) session was also held at the 2012 conference. RESULTS: Three distinct themes emerged regarding Black MSM engagement and participation in HIV vaccine research: (1) community-based organizations as true partners, (2) investment in the Black gay community, and (3) true efforts to inform and educate the community. CONCLUSIONS: A key focus for improving efforts to engage the Black MSM community in preventive HIV clinical trials is building and maintaining equitable and reciprocal partnerships among research institutions, Black-led AIDS service organizations and community-based organizations, and community members.
Authors: Kalpana Gupta; Michael Hudgens; Lawrence Corey; M Juliana McElrath; Kent Weinhold; David C Montefiori; Geoffrey J Gorse; Sharon E Frey; Michael C Keefer; Thomas G Evans; Raphael Dolin; David H Schwartz; Clayton Harro; Barney Graham; Paul W Spearman; Mark Mulligan; Paul Goepfert Journal: J Acquir Immune Defic Syndr Date: 2002-03-01 Impact factor: 3.731
Authors: Mary A Allen; Thomas S Liang; Thomas La Salvia; Brian Tjugum; Robert J Gulakowski; Matthew Murguía Journal: J Acquir Immune Defic Syndr Date: 2005-12-15 Impact factor: 3.731
Authors: Spencer Lieb; Stephen J Fallon; Samuel R Friedman; Daniel R Thompson; Gary J Gates; Thomas M Liberti; Robert M Malow Journal: Public Health Rep Date: 2011 Jan-Feb Impact factor: 2.792
Authors: Gaston Djomand; Joanna Katzman; Dante di Tommaso; Michael G Hudgens; George W Counts; Beryl A Koblin; Patrick S Sullivan Journal: Public Health Rep Date: 2005 Sep-Oct Impact factor: 2.792
Authors: R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen Journal: J Acquir Immune Defic Syndr Date: 2001-01-01 Impact factor: 3.731
Authors: David C Montefiori; Marcus Altfeld; Paul K Lee; Miroslawa Bilska; Jintao Zhou; Mary N Johnston; Feng Gao; Bruce D Walker; Eric S Rosenberg Journal: J Immunol Date: 2003-04-01 Impact factor: 5.422
Authors: J A Kelly; J S St Lawrence; Y E Diaz; L Y Stevenson; A C Hauth; T L Brasfield; S C Kalichman; J E Smith; M E Andrew Journal: Am J Public Health Date: 1991-02 Impact factor: 9.308
Authors: Meredith E Clement; Nwora L Okeke; Terry Munn; Miguel Hunter; Kareem Alexis; Amy Corneli; Arlene C Seña; Kara McGee; Mehri S McKellar Journal: J Acquir Immune Defic Syndr Date: 2018-02-01 Impact factor: 3.731
Authors: Russell Brewer; Chris Daunis; Sabira Ebaady; Leo Wilton; Sarah Chrestman; Snigdha Mukherjee; Mary Moore; Renee Corrigan; John Schneider Journal: J Racial Ethn Health Disparities Date: 2019-02-21
Authors: Patrick A Wilson; Pamela Valera; Alexander J Martos; Natalie M Wittlin; Miguel A Muñoz-Laboy; Richard G Parker Journal: J Sex Res Date: 2015-08-04
Authors: Audrey Harkness; Brooke G Rogers; Raymond Balise; Daniel Mayo; Elliott R Weinstein; Steven A Safren; John E Pachankis Journal: AIDS Behav Date: 2021-01-23
Authors: Michelle R Kaufman; Flora Cornish; Rick S Zimmerman; Blair T Johnson Journal: J Acquir Immune Defic Syndr Date: 2014-08-15 Impact factor: 3.731
Authors: Darrell P Wheeler; Jonathan Lucas; Leo Wilton; LaRon E Nelson; Christopher Hucks-Ortiz; C Chauncey Watson; Craig Hutchinson; Kenneth H Mayer; Irene Kuo; Manya Magnus; Geetha Beauchamp; Steven Shoptaw; Lynda Marie Emel; Ying Q Chen; Lisa Hightow-Weidman; Sheldon D Fields Journal: J Int AIDS Soc Date: 2018-10 Impact factor: 5.396